MedTrace Logo

Brimonidine for Intraoperative Hemostasis

NCT05480098 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2025-01-15

No results posted yet for this study

Summary

The purpose of this study is to observe and report the effects of topical ophthalmic brimonidine in oculofacial plastic surgery.

Conditions

  • Dermatochalasis of Eyelid
  • Ptosis, Eyelid
  • Ectropion
  • Entropion

Interventions

DRUG

Brimonidine Topical

Topical brimonidine intraoperatively for hemostasis

Sponsors & Collaborators

  • University of Louisville

    lead OTHER

Principal Investigators

  • Christopher Compton, MD · University of Louisville

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-26
Primary Completion
2024-05-22
Completion
2024-05-22
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05480098 on ClinicalTrials.gov